NasdaqGM - Delayed Quote
USD
Oaktree Acquisition Corp. III Life Sciences (OACC)
10.72
0.00
(0.00%)
At close: October 30 at 4:00:00 PM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. George A. Martinez
|
CFO, Principal Accounting & Principal Financial Officer | -- | -- | 1985 |
|
Mr. Mathew M. Pendo
|
Chief Operation Officer | -- | -- | 1964 |
Oaktree Acquisition Corp. III Life Sciences
333 South Grand Avenue
28th Floor
Los Angeles, CA 90071
United States
- Sector:
- Financial Services
- Industry: Shell Companies
Description
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Corporate Governance
Oaktree Acquisition Corp. III Life Sciences’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
